Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer

Cell Cycle

Volumn 14, Issue 15, 2015, Pages 2473-2483

  Ji, Runbi ^a   Zhang, Bin ^a   Zhang, Xu ^a   Xue, Jianguo ^a   Yuan, Xiao ^a   Yan, Yongmin ^a   Wang, Mei ^a   Zhu, Wei ^a   Qian, Hui ^a   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Drug resistance; Exosomes; Gastric cancer; Mesenchymal stem cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CD63 ANTIGEN; CD9 ANTIGEN; CISPLATIN; FLUOROURACIL; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MULTIDRUG RESISTANCE PROTEIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; RAF PROTEIN; VEMURAFENIB; ANTINEOPLASTIC ANTIMETABOLITE; CARRIER PROTEIN; CASK KINASES; GUANYLATE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVATION; EX VIVO STUDY; EXOSOME; FETUS; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; ANIMAL; BAGG ALBINO MOUSE; CELL COMMUNICATION; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL COMMUNICATION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; EXOSOMES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUOROURACIL; GUANYLATE KINASES; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE TRANSPORT PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; RAF KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 84943759485     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1005530     Document Type: Article

References (29)

1. Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM, Gerritsen MG, Schipper HS, Backer MJ, van Amersfoort M, et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 2011; 20(3): 370-83; PMID: 21907927; http://dx. doi. org/10. 1016/j. ccr. 2011. 08. 010.
2. Cukierman E, Bassi DE. The mesenchymal tumor microenvironment: a drug-resistant niche. Cell Adh Migr 2012; 6(3): 285-96; PMID: 22568991; http://dx. doi. org/10. 4161/cam. 20210.
3. Zhu W, Huang L, Li Y, Qian H, Shan X, Yan Y, Mao F, Wu X, Xu WR. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell Cycle 2011; 10(18): 3198-207; PMID: 21900753; http://dx. doi. org/10. 4161/cc. 10. 18. 17638.
4. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 2012; 315(1): 28-37; PMID: 22055459; http://dx. doi. org/10. 1016/j. canlet. 2011. 10. 002.
5. Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013; 22(6): 845-54; PMID: 23002959; http://dx. doi. org/10. 1089/scd. 2012. 0395.
6. Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y, Zhang B, Wang M, Mao F, Yan Y, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013 Apr; 4(2): 34; http://dx. doi. org/10. 1186/scrt194.
7. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013 Dec; 32(3-4): 623-42; http://dx. doi. org/10. 1007/s10555-013-9441-9.
8. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501(7467): 346-54; PMID: 24048067; http://dx. doi. org/10. 1038/nature12626.
9. Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, et al. Docetaxelresistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 2012; 7 (12): e50999; http://dx. doi. org/10. 1371/journal. pone. 0050999.
10. Xiao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu Y, Feng J. Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS One 2014; 9(2): e89534; PMID: 24586853; http://dx. doi. org/10. 1371/journal. pone. 0089534.
11. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 2003; 63(15): 4331-7; PMID: 12907600.
12. Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, Zhou B, Xu H. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2013; 13: 577; PMID: 24304886; http://dx. doi. org/10. 1186/1471-2407-13-577.
13. Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, et al. Treatment of gastric cancer. World J Gastroenterol 2014; 20(7): 1635-49; PMID: 24587643; http://dx. doi. org/10. 3748/wjg. v20. i7. 1635.
14. Kwee RM, Kwee TC. Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer. World J Gastroenterol 2014; 20(7): 1650-56; PMID: 24587644; http://dx. doi. org/10. 3748/wjg. v20. i7. 1650.
15. Chien J, Kuang R, Landen C, Shridhar V. Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment. Front Oncol 2013; 3: 251; PMID: 24069583; http://dx. doi. org/10. 3389/fonc. 2013. 00251.
16. Mao Y, Keller ET, Garfield DH, Shen K, Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 2013; 32(1-2): 303-15; PMID: 23114846; http://dx. doi. org/10. 1007/s10555-012-9415-3.
17. Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, Jiang R, Yan Y, Mao F, Yang H, et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 2008; 32(1): 8-15; PMID: 17904875; http://dx. doi. org/10. 1016/j. cellbi. 2007. 08. 002.
18. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 2013 Oct; 13(10): 714-26; http://dx. doi. org/10. 1038/nrc3599.
19. Riganti C, Doublier S, Viarisio D, Miraglia E, Pescarmona G, Ghigo D, Bosia A. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1aand P-glycoprotein overexpression. Br J Pharmacol 2009; 156 (7): 1054-66; PMID: 19298255; http://dx. doi. org/10. 1111/j. 1476-5381. 2009. 00117. x.
20. Guan J, Chen J. Mesenchymal stem cells in the tumor microenvironment. Biomed Rep 2013; 1(4): 517-21; PMID: 24648978.
21. Houthuijzen JM, Daenen LG, Roodhart JM, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumor progression. Br J Cancer 2012; 106(12): 1901-6; PMID: 22596239; http://dx. doi. org/10. 1038/bjc. 2012. 201.
22. Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011; 32: 964-72; PMID: 21317300; http://dx. doi. org/10. 1093/carcin/bgr029.
23. De Boeck A, Pauwels P, Hensen K, Rummens JL, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems G, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 2013; 62: 550-60; PMID: 22535374; http://dx. doi. org/10. 1136/gutjnl-2011-301393.
24. Vianello F, Villanova F, Tisato V, Lymperi S, Ho KK, Gomes AR, Marin D, Bonnet D, Apperley J, Lam EW, et al. Bone marrow mesenchymal stromal cells nonselectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis. Haematologica 2010; 95(7): 1081-9; PMID: 20179085; http://dx. doi. org/10. 3324/haematol. 2009. 017178.
25. Rodriguez-Mora O, LaHair MM, Howe CJ, McCubrey JA, Franklin RA. Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy. Expert Opin Ther Targets 2005; 9(4): 791-808; PMID: 16083343; http://dx. doi. org/10. 1517/14728222. 9. 4. 791.
26. McCubrey JA, Abrams SL, Stadelman K, Chappell WH, Lahair M, Ferland RA, Steelman LS. Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells. Adv Enzyme Regul 2010; 50(1): 285-307; PMID: 19895837; http://dx. doi. org/10. 1016/j. advenzreg. 2009. 10. 016.
27. Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, Azzam DJ, Victor CTS, Wiemann BZ, Ishwaran H, et al. Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways. Cell 2014; 159(3): 499-513; PMID: 25417103; http://dx. doi. org/10. 1016/j. cell. 2014. 09. 051.
28. Wang J, Hendrix A, Hernot S, Lemaire M, Bruyne ED, Valckenborgh EV, Lahoutte T, Wever OD, Vanderkerken K, Menu E. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood 2014; 124(4): 555-66; PMID: 24928860; http://dx. doi. org/10. 1182/blood-2014-03-562439.
29. Shelke GV, Lässer C, Gho YS, Lötvall J. Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum. J Extracell Vesicles 2014; 3: 24783.